Anatomical evidence for transsynaptic influences of estrogen on brain-derived neurotrophic factor expression
- PMID: 14681930
- DOI: 10.1002/cne.10989
Anatomical evidence for transsynaptic influences of estrogen on brain-derived neurotrophic factor expression
Abstract
Several studies have demonstrated that estrogen modulates brain-derived neurotrophic factor (BDNF) mRNA and protein within the adult hippocampus and cortex. However, mechanisms underlying this regulation are unknown. Although an estrogen response element (ERE)-like sequence has been identified within the BDNF gene, such a classical mechanism of estrogen-induced transcriptional activation requires the colocalized expression of estrogen receptors within cells that produce BDNF. Developmental studies have demonstrated such a relationship, but to date no studies have examined colocalization of estrogen receptors and BDNF within the adult brain. By utilizing double-label immunohistochemistry for BDNF, estrogen receptor-alpha (ER-alpha), and estrogen receptor-beta (ER-beta), we found only sparse colocalization between ER-alpha and BDNF in the hypothalamus, amygdala, prelimbic cortex, and ventral hippocampus. Furthermore, ER-beta and BDNF do not colocalize in any brain region. Given the recent finding that cortical ER-beta is almost exclusively localized to parvalbumin-immunoreactive GABAergic neurons, we performed BDNF/parvalbumin double labeling and discovered that axons from cortical ER-beta-expressing inhibitory neurons terminate on BDNF-immunoreactive pyramidal cells. Collectively, these findings support a potential transsynaptic relationship between estrogen state and cortical BDNF: By directly modulating GABAergic interneurons, estrogen may indirectly influence the activity and expression of BDNF-producing cortical neurons.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Estradiol-induced modulation of estrogen receptor-beta and GABA within the adult neocortex: a potential transsynaptic mechanism for estrogen modulation of BDNF.J Comp Neurol. 2006 Dec 1;499(4):603-12. doi: 10.1002/cne.21122. J Comp Neurol. 2006. PMID: 17029253
-
Estrogen receptor-beta colocalizes extensively with parvalbumin-labeled inhibitory neurons in the cortex, amygdala, basal forebrain, and hippocampal formation of intact and ovariectomized adult rats.J Comp Neurol. 2002 Oct 21;452(3):276-87. doi: 10.1002/cne.10393. J Comp Neurol. 2002. PMID: 12353223
-
Estrogen is more than just a "sex hormone": novel sites for estrogen action in the hippocampus and cerebral cortex.Front Neuroendocrinol. 2000 Jan;21(1):95-101. doi: 10.1006/frne.1999.0190. Front Neuroendocrinol. 2000. PMID: 10662537 Review.
-
Direct, complex effects of estrogens on basal forebrain cholinergic neurons.Exp Neurol. 2005 Aug;194(2):506-22. doi: 10.1016/j.expneurol.2005.03.015. Exp Neurol. 2005. PMID: 15893308
-
Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol.Ann N Y Acad Sci. 2005 Jun;1052:136-44. doi: 10.1196/annals.1347.009. Ann N Y Acad Sci. 2005. PMID: 16024756 Review.
Cited by
-
The intersection between menopause and depression: overview of research using animal models.Front Psychiatry. 2024 Jul 15;15:1408878. doi: 10.3389/fpsyt.2024.1408878. eCollection 2024. Front Psychiatry. 2024. PMID: 39081530 Free PMC article. Review.
-
Central expression and anorectic effect of brain-derived neurotrophic factor are regulated by circulating estradiol levels.Horm Behav. 2013 Mar;63(3):533-42. doi: 10.1016/j.yhbeh.2013.01.009. Epub 2013 Jan 31. Horm Behav. 2013. PMID: 23376487 Free PMC article.
-
Estrogen-BDNF interactions: implications for neurodegenerative diseases.Front Neuroendocrinol. 2006 Dec;27(4):404-14. doi: 10.1016/j.yfrne.2006.09.003. Epub 2006 Oct 27. Front Neuroendocrinol. 2006. PMID: 17069877 Free PMC article. Review.
-
Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1.Neuroscience. 2014 Feb 28;260:106-19. doi: 10.1016/j.neuroscience.2013.12.023. Epub 2013 Dec 17. Neuroscience. 2014. PMID: 24361177 Free PMC article.
-
Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders.J Pharmacol Exp Ther. 2017 Jan;360(1):48-58. doi: 10.1124/jpet.116.237412. Epub 2016 Oct 27. J Pharmacol Exp Ther. 2017. PMID: 27789681 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources